These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16823693)

  • 1. Immunohistochemical expression of progesterone and estrogen receptors in meningiomas.
    Omulecka A; Papierz W; Nawrocka-Kunecka A; Lewy-Trenda I
    Folia Neuropathol; 2006; 44(2):111-5. PubMed ID: 16823693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
    Hernández Faraco A; Céspedes G; Trejo E
    Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
    Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
    Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas.
    Fakhrjou A; Meshkini A; Shadrvan S
    Pak J Biol Sci; 2012 Jun; 15(11):530-5. PubMed ID: 24191627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
    Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
    J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
    Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
    Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas.
    Carroll RS; Brown M; Zhang J; DiRenzo J; Font De Mora J; Black PM
    Clin Cancer Res; 2000 Sep; 6(9):3570-5. PubMed ID: 10999746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data.
    Bouillot P; Pellissier JF; Devictor B; Graziani N; Bianco N; Grisoli F; Figarella-Branger D
    J Neurosurg; 1994 Nov; 81(5):765-73. PubMed ID: 7523635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
    Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
    Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas.
    Khalid H
    Cancer; 1994 Jul; 74(2):679-85. PubMed ID: 8033047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progesterone receptors in meningiomas.
    Maiuri F; Montagnani S; Gallicchio B
    Surg Neurol; 1986 Nov; 26(5):435-40. PubMed ID: 3764648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data.
    Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays.
    Halper J; Colvard DS; Scheithauer BW; Jiang NS; Press MF; Graham ML; Riehl E; Laws ER; Spelsberg TC
    Neurosurgery; 1989 Oct; 25(4):546-52; discussion 552-3. PubMed ID: 2477767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperstosis in patients with intracranial meningioma--secondary changes in tumor invasion].
    Kvasha MS
    Lik Sprava; 2002; (3-4):90-3. PubMed ID: 12145904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptor in meningiomas: An immunohistochemical analysis.
    Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Mowliswara Prasad BC; Reddy MK
    J Cancer Res Ther; 2020; 16(6):1482-1487. PubMed ID: 33342817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells.
    Leães CG; Meurer RT; Coutinho LB; Ferreira NP; Pereira-Lima JF; da Costa Oliveira M
    Neuropathology; 2010 Feb; 30(1):44-9. PubMed ID: 19703265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
    Hsu DW; Efird JT; Hedley-Whyte ET
    J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC4 expression in meningiomas: under-recognized immunophenotype particularly in meningothelial and angiomatous subtypes.
    Matsuyama A; Jotatsu M; Uchihashi K; Tsuda Y; Shiba E; Haratake J; Hisaoka M
    Histopathology; 2019 Jan; 74(2):276-283. PubMed ID: 30112770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.